Q1 2026
Released May 7, 2026, after the close
10-Q filed May 7, 2026, 37 days after period end · 0001493152-26-021701
Q1 2026 · 10-Q
Revenue$5.21M$5.21M +6.9% vs Q1 2025+10.2% vs Q4 2025
Net Income$140.00K$140.00K −74.9% vs Q1 2025+125.8% vs Q4 2025
EPS Diluted$0.01$0.01 −80.0% vs Q1 2025no prior Q4 2025 on file
Gross Profit$2,993,000−5.1%
Operating Income$97,000−82.9%
Operating Cash Flow-$1,671,000N/M
Margins · derived
Gross margin57.4%−7.2 pt vs Q1 2025
Operating margin1.9%−9.7 pt vs Q1 2025
Net margin2.7%−8.8 pt vs Q1 2025
What the release said
The release
Same quarter
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $5.21M | $4.88M | $3.52M | $3.70M |
| Net Income | $140.00K | $558.00K | -$169.00K | -$306.00K |
| EPS Diluted | $0.01 | $0.05 | -$0.02 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR